Elanco Animal Health (ELAN) Tops Q4 EPS by 3c, Offers Guidance

Elanco Animal Health (NYSE: ELAN) reported Q4 EPS of $0.12, $0.03 better than the analyst estimate of $0.09. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.06 billion.

GUIDANCE:

Elanco Animal Health sees Q1 2021 EPS of $0.20-$0.25, versus the consensus of $0.22. Elanco Animal Health sees Q1 2021 revenue of $1.15-1.17 billion, versus the consensus of $1.13 billion.

Elanco Animal Health sees FY2021 EPS of $0.90-$1.00, versus the consensus of $0.90. Elanco Animal Health sees FY2021 revenue of $4.55-4.63 billion, versus the consensus of $4.56 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• McCormick & Co. (MKC) Tops Q2 EPS by 10c ; Offers Guidance
• SYNNEX Corp. (SNX) Tops Q2 EPS by 74c, Beats on Revenue; Offers Q3 Guidance